📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features. (2018)

First Author: Pariani N

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/jc.2018-00359

PubMed Identifier: 29878256

Publication URI: http://europepmc.org/abstract/MED/29878256

Type: Journal Article/Review

Volume: 103

Parent Publication: The Journal of clinical endocrinology and metabolism

Issue: 8

ISSN: 0021-972X